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Plasmodium falciparum causes the most severe form of malaria in humans and invades erythrocytes using
multiple ligand-receptor interactions. Two important protein families involved in erythrocyte binding are the
erythrocyte binding-like (EBL) and the reticulocyte binding-like (RBL or P. falciparum Rh [PfRh]) proteins.
We constructed P. falciparum lines lacking expression of EBL proteins by creating single and double knockouts
of the corresponding genes for eba-175, eba-181, and eba-140 and show that the EBL and PfRh proteins function
cooperatively, consistent with them playing a similar role in merozoite invasion. We provide evidence that PfRh
and EBL proteins functionally interact, as loss of function of EBA-181 ablates the ability of PfRh2a/b protein
antibodies to inhibit merozoite invasion. Additionally, loss of function of some ebl genes results in selection for
increased transcription of the PfRh family. This provides a rational basis for considering PfRh and EBL
proteins for use as a combination vaccine against P. falciparum. We immunized rabbits with combinations of
PfRh and EBL proteins to test the ability of antibodies to block merozoite invasion in growth inhibition assays.
A combination of EBA-175, PfRh2a/b, and PfRh4 recombinant proteins induced antibodies that potently
blocked merozoite invasion. This validates the use of a combination of these ligands as a potential vaccine that
would have broad activity against P. falciparum.
Plasmodium falciparum causes the most severe form of
malaria in humans (43). The asexual blood stage multiplies
in erythrocytes and is responsible for the disease manifes-
tations of malaria (29). Merozoites are released from eryth-
rocytes every 48 h, and these rapidly invade new red blood
cells (RBCs) in a complex process involving multiple steps
and a cascade of ligand-receptor interactions (reviewed in
reference 8).
While the function of different parasite ligands in merozoite
invasion is not fully understood, the erythrocyte binding-like
(EBL) and reticulocyte binding-like (RBL or P. falciparum Rh
[PfRh]) homologues have been shown to play a central role (9,
10, 12–14, 24, 36, 40, 44, 47, 50–52). Five genes that potentially
encode EBL proteins have been identified, and this group
includes the erythrocyte binding antigen 175 (EBA-175;
MAL7P1.176) (33, 40), EBA-181 (also known as JESEBL;
PFA0125c) (16, 28), and EBA-140 (also known as BAEBL;
MAL13P1.60) (24, 27, 30, 48). EBL-1 (PF13_0115) is not ex-
pressed in some parasite lines, as it has missense mutations
within the coding region. However, it is functional in some
lines and may play an important role in P. falciparum invasion
in the field (26). The gene encoding EBA-165 (PFD1155w)
also has missense mutations, suggesting that it is a pseudogene,
but its expression has yet to be detected in any parasite line
(53). The EBL proteins consist of the F region (region II),
which is made up of two related domains (domains F1 and F2)
that are involved in receptor binding (33, 39, 40). EBA-175 and
EBA-140 bind to glycophorins A and C, respectively, and these
interactions are sialic acid dependent (1, 21, 24, 27, 32, 39, 48).
The receptor for EBA-181 is still unknown, although its phys-
ical properties show that it is neuraminidase sensitive, trypsin
resistant, and chymotrypsin sensitive (16). EBA-181 has been
shown to bind to erythrocyte protein 4.1, although this is un-
likely to be its host receptor (19).
EBA-175 is polymorphic in region II, the binding region of
this ligand, and appears to be under diversifying selection (6).
In contrast, EBA-140 and EBA-181 have few polymorphisms
in the equivalent domain (28). The polymorphisms in the bind-
ing regions of EBA-140 and EBA-181 have been suggested to
alter their respective receptor specificities (28). In contrast,
other studies have shown that these polymorphisms affect
EBA-140 and EBA-181 receptor-binding affinity but not their
receptor specificity (22). A correlation between decreased
EBA-140 binding and its functional contribution in merozoite
invasion has been shown (22, 24). This suggests that sequence
variability in individual EBL proteins is driven by immune
selection but not by receptor selectivity.
The PfRh family consists of PfRh1 (PFD0110w), PfRh2a
(PF13_0198), PfRh2b (MAL13P1.176), PfRh3 (PFL2520w),
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PfRh4 (PFD1150c), and PfRh5 (PFD1145c). PfRh3 appears to
be a transcribed pseudogene, at least for the P. falciparum lines
analyzed (45). PfRh1 undergoes protease cleavage events (51),
and the N-terminal region has been shown to bind to erythro-
cytes in a sialic acid-dependent and protease-sensitive manner
(36, 52). Genetic disruption of the PfRh1 gene in P. falciparum
resulted in a decrease in the sialic acid dependence of mero-
zoite invasion, showing that this ligand plays a direct role in
this process (50). Additionally, antibodies raised to the PfRh1
binding region inhibit merozoite invasion (13). In contrast,
PfRh4 binds to erythrocytes in a sialic acid-independent and
protease-sensitive manner, suggesting that it binds directly to a
protein receptor (14, 18, 44) and antibodies against PfRh4 can
directly inhibit the function of this ligand in invasion (47).
PfRh2a and PfRh2b share a region comprising over 80% of the
protein and differ only in the C-terminal sequence. PfRh2b has
not been shown to directly bind to erythrocytes, but disruption
of the gene and inhibition of merozoite invasion using specific
antibodies have shown that it plays an important role in inva-
sion through a candidate receptor, Z (9, 10, 12). PfRh2a has
also not been demonstrated to bind to erythrocytes, and at this
stage it is not clear if it plays an important role in merozoite
invasion (10, 12). PfRh5 is an atypical member of the PfRh
family; it is a much smaller protein and does not have a trans-
membrane region (3, 17). It binds to erythrocytes in a sialic
acid-independent manner, although its receptor has yet to be
identified. While the receptors for EBA-175 and EBA-140
have been characterized, for the PfRh family of proteins, only
the receptor for PfRh4 has been identified, with complement
receptor 1 (CR1) shown to be the receptor mediating a specific
invasion pathway (46).
EBL and PfRh proteins are located in the apical organelles
of the merozoite and are released onto the surface during
invasion of erythrocytes (12, 41, 51). Current evidence suggests
that the EBA and PfRh proteins are targets of human inva-
sion-inhibitory antibodies and important components of ac-
quired protective immunity (35). It has been shown that dif-
ferential expression and activation of PfRh proteins provide a
mechanism for phenotypic variation in invasion by P. falcipa-
rum (12, 35, 44). Disruption of the EBA-175 gene in parasite
line W2mef selects for parasites that have activated a normally
silenced PfRh4 gene (4, 11, 14, 44). P. falciparum strains can
differentially express PfRh2a and PfRh2b, with some lacking
any detectable protein, despite the presence of intact genes,
suggesting that they too are silenced and under appropriate
selection could be activated. Phenotypic variation of the PfRh
and EBL families is a mechanism to vary use of invasion
pathways (11, 14, 44), creating a hierarchy of invasion ligands
that may allow parasites to escape antibody-mediated host
immune responses (35) or adapt to variation in erythrocyte
surface receptors (4, 12). These studies have provided impor-
tant insights into the function of the EBA and PfRh proteins
and raised them to be possible vaccine candidates. However, in
order to block the broad array of receptor-ligand interactions
that the parasite has available, a vaccine that targets a combi-
nation of the PfRh and EBA proteins would be required.
In order to better understand the role of the EBA and PfRh
family of proteins in erythrocyte invasion, we have constructed
single- and double-gene-knockout strains in P. falciparum and
tested these parasites for growth and invasion. This study
shows that loss of function of EBL proteins can be compen-
sated for by increased expression of PfRh ligands. Addition-
ally, we have evaluated a combination of EBL and PfRh pro-
teins for potential use as a vaccine by testing their ability to
induce antibodies that block a broad array of ligand-receptor
interactions and thereby effectively inhibit merozoite invasion.
MATERIALS AND METHODS
Parasite culture, plasmid vectors, and transfection. P. falciparum asexual
stages were maintained in human type O-positive erythrocytes and synchronized
by standard methods (49). 3D7 is a cloned line derived from NF54, supplied by
David Walliker, Edinburgh University. The vectors used for construction of the
gene-knockout strains were pCC1 and pCC4 (25). For disruption of EBA-175,
pCC1 was used, and the 5 flank was 565 bp starting at 14 bp from the ATG site
and was cloned into the SpeI/BglII sites. The 3 flank was 1,486 bp starting at
2,254 bp and was cloned into ClaI and AvrII. For disruption of EBA-181, pCC1
and pCC4 were used, and for both vectors, the 5 flank was 775 bp starting at 10
bp from the ATG site and was cloned using the restriction enzymes SacII/SpeI.
The 3 flank was 1,257 bp starting at 1,516 bp and was cloned using ClaI and
AvrII. For disruption of EBA-140, pCC4 was used, and the 5 flank was 938 bp
starting at 17 bp from the ATG site and was cloned using the restriction
enzymes SpeI/BglII. The 3 flank was 945 bp starting at 2,433 bp and was cloned
using EcoR I and AvrII.
Transfection with 80 g of purified plasmid DNA (Qiagen, Hilden, Germany)
and selection for stable transfectants were performed as described previously
(23). Successful disruption of the targeted genes was confirmed by Southern blot
analysis, using the Roche digoxigenin (DIG) system, according to the manufac-
turer’s instructions. Each transfected line was cloned by limiting dilution, and all
analyses were performed on these parasites.
Coculture assay. Cultures of P. falciparum 3D7, 3D7EBA-175, 3D7EBA-
181, 3D7EBA-140, 3D7EBA-175/181, and 3D7EBA-175/140 parasite lines
were synchronized with 5% sorbitol twice 16 h apart. The parasitemia was
determined by fluorescence-activated cell sorter (FACS; FACSCalibur; BD)
analysis and was adjusted to 0.5% parasitemia and 4% hematocrit. Trophozoite-
infected RBCs were used to set up the assay. Once the parasitemia had been
adjusted, the parasitemia was then rechecked by FACS analysis to confirm the
correct parasitemia. Assays were set up in 10-ml petri dishes containing 5 ml of
3D7 parasites and 5 ml from the different knockout parasite lines in the absence
of WR99210 and/or blasticidin. The mixed cultures were maintained at about 1%
parasitemia and 4% hematocrit by adding fresh erythrocytes every 2 days, and on
every fourth day infected erythrocytes were collected to make genomic DNA
(gDNA). The assay was performed over 5 weeks. Real-time PCR was performed
on a LightCycler 480 real-time PCR system (Roche) in 10-l reaction mixtures
using the LightCycler 480 SYBR green I master mix (Roche). The PCR condi-
tions consisted of an initial incubation at 95°C for 10 min and then 45 cycles at
95°C for 10 s, 58°C for 10 s, and 72°C for 10 s. Fluorescence was acquired at the
end of each extension phase, and melting curve analysis was performed on each
reaction mixture to determine the specificity of amplification. Two microliters of
genomic DNA was used per PCR, and all samples were tested in duplicate.
Water was used as a negative control, and serial dilutions of gDNA (five dilu-
tions, 1-, 10-, 100-, 1,000-, and 10,000-fold concentrations) were used to generate
standard curves for each gene. The amount of each target gene was estimated
using the standard curve. The absolute quantification method was used to mea-
sure the copy number of genes for each sample. The primers (sequences) for
target genes were as follows: eba-175 forward primer (5-TTCGTGATGAGTG
GTGGAAA-3), eba-175 reverse primer (5-GGCAATAATCATCACCCCAT
T-3), eba-181 forward primer (5-GATTCTGGAATGGGGGAAAT-3), eba-
181 reverse primer (5-TACATCCGGTTGAGCAGTCA-3), eba-140 forward
primer (5-CGCGGAAGAACCTCAAATTA-3), eba-140 reverse primer (5-G
GAAGCCTACATCCACCAAA-3), hdhfr forward primer (5-CTCAAGGAA
CCTCCACAAGG-3), hdhfr reverse primer (5-GTTTAAGATGGCCTGGGT
GA-3), bsd forward primer (5-TTTTACTGGGGGACCTTGTG-3), and bsd
reverse primer (5-CAAGATGCCCCTGTTCTCAT-3).
Primers for ebl genes were designed to amplify in 3D7 parasites only, and
primers for blasticidin deaminase (bsd) and human dihydrofolate reductase
(hDHFR) genes were designed to amplify the gene-knockout mutant parasite
lines. The relative concentration of target genes was normalized to that of the
aldolase gene at the initial time point (time zero). The normalized data were
then used to generate a ratio when they were compared to those for aldolase.
Using the normalized data for the target gene over those for aldolase generated
the relative concentration of the copy number for the different parasite lines.
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Two-sided t tests were used to test for differences in gene copy numbers between
3D7 and ebl-knockout mutant lines.
Antibody generation. Rabbit antibodies were raised to Escherichia coli-ex-
pressed fusion proteins PfRh4 and PfRh2a/b and were named PfRh4-9 (47) and
Rh2a9 (12), respectively. Antibodies to EBA-175 were to regions III to V (EBA-
175RIII-V), corresponding to amino acids 761 to 1298 (37). Antibodies to EBA-
181 were to regions III to V, corresponding to amino acids 755 to 1339 (16).
Antibodies to EBA-140 were to the F2 domain, corresponding to amino acids
746 to 1043 (24, 48). Rabbits were injected with combinations of each antigen (75
g) in Freund’s complete adjuvant, followed by two immunizations (75 g) in
Freund’s incomplete adjuvant. This was followed by three immunizations (50 g)
in phosphate-buffered saline (PBS). The first blood sample (bleed) was taken
after injection three, the second bleed after injection four, and the third bleed
after injection six.
Immunoblotting. Proteins were separated on 3 to 8% Tris acetate SDS-poly-
acrylamide gels (Invitrogen). Western blotting onto nitrocellulose (Invitrogen)
was performed according to standard protocols, and blots were processed with an
enhanced chemiluminescence system (ECL; Amersham).
ELISA. Enzyme-linked immunosorbent assays (ELISAs) were performed as
described previously (35). Ninety-six-well flat-bottom plates (Maxisorp; Nunc)
were coated with recombinant fusion protein at a concentration of 1 g/ml in
human tonicity PBS (HT-PBS) overnight at 4°C. Plates were incubated with 10%
skim milk–0.05% Tween 20 for 2 h at 37°C to block unspecific binding. After the
plates were washed, samples were applied diluted in 5% skim milk–0.05% Tween
20. Plates were incubated for 1 h at room temperature before serum was re-
moved by washing. Secondary antibody (horseradish peroxidase [HRP]-conju-
gated goat anti-human antibody; Chemicon) was used at a 1:5,000 dilution in 5%
skim milk–0.05% Tween 20. Plates were incubated for 1 h at room temperature.
Azino-bis-3-ethylbenthiazoline-6-sulfonic acid (liquid substrate system; Sigma-
Aldrich) was used to detect HRP activity. The reaction was stopped with 1%
SDS, and the optical density (OD) was measured at 405 nm. All washes were
done in 1 HT-PBS–0.05% Tween 20. All samples were tested in duplicate. The
OD from wells incubated with PBS instead of serum was considered the back-
ground level and was deducted from the ODs of all samples.
Growth inhibition assay. Growth inhibition assays (GIAs) were performed as
described previously (34). Briefly, late-trophozoite-stage parasites were added to
erythrocytes to give a parasitemia of 0.2% and an hematocrit of 1% in 96-well
round-bottom microtiter plates (Becton Dickinson, Franklin Lakes, NJ). Five
microliters of purified rabbit IgG was added to a final concentration of 2 mg/ml.
For the antibody titrations, inhibitory antibodies were added to final concentra-
tions of 0.125, 0.25, 0.5, 1, and 2.0 mg/ml. Cultures were supplemented with 10
l of culture medium after 48 h (one cycle) of growth. After incubation with
antibodies for two cycles of parasite growth (80 to 96 h), the parasitemia of each
well was counted by flow cytometry using ethidium bromide (10 g/ml; Bio-Rad,
Hercules, CA) to stain trophozoite-stage parasites using a FACSCalibur appa-
ratus with a plate reader (Becton Dickinson). For each well, more than 40,000
cells were counted; all samples were tested in triplicate. Growth was expressed as
a percentage of the parasitemia of the mean parasitemia of six rabbit preimmu-
nization IgG samples. Three independent assays were performed for the parasite
lines, each with triplicate wells.
RNA extraction and reverse transcription. Highly synchronized cultures at late
schizont stage were used to extract RNA. Parasites were in 30-ml cultures at
5% parasitemia and 4% hematocrit. Schizont-stage parasites were resus-
pended in ice-cold saponin, and RNA was extracted from saponin pellets using
a Qiagen RNeasy kit (Qiagen), according to the manufacturer’s instructions.
RNA was stored in RNase-free water at 80°C. RNA was quantified using a
NanoDrop 1000 spectrophotometer (Thermo Scientific).
One microgram of total RNA was reverse transcribed using a Superscript III
first-strand reverse transcription kit (Invitrogen), according to the manufactur-
er’s instructions. The resultant cDNA was used for subsequent analysis by quan-
titative real-time PCR.
Quantitative real-time PCR. Real-time PCR was performed on a LightCycler
480 real-time PCR system (Roche) in 10-l reaction mixtures using LightCycler
480 SYBR green I master mix (Roche) (31). The PCR conditions consisted of an
initial incubation at 95°C for 10 min and then 45 cycles at 95°C for 10 s, 58°C for
10 s, and 72°C for 10 s. Fluorescence was acquired at the end of each extension
phase, and melting curve analysis was performed on each reaction mixture to
determine specificity. Two microliters of cDNA was used per PCR, and all
samples were tested in duplicate. Water was used as a negative control, and serial
dilutions of cDNA (five dilutions, 1-, 10-, 100-, 1,000-, and 10,000-fold concen-
trations) were used to generate standard curves for each gene. The amount of
each transcript was estimated using the standard curve. The relative quantifica-
tion method was used to determine the differential gene expression and to
calculate the concentrations of each sample. The primers (sequences) for target
genes were as follows: EBA-175 forward primer (5-TTCGTGATGAGTGGTG
GAAA-3), EBA-175 reverse primer (5-GGCAATAATCATCACCCCATT-
3), EBA-181 forward primer (5-GATTCTGGAATGGGGGAAAT-3), EBA-
181 reverse primer (5-TACATCCGGTTGAGCAGTCA-3), EBA-140 forward
primer (5-CGCGGAAGAACCTCAAATTA-3), EBA-140 reverse primer (5-
GGAAGCCTACATCCACCAAA-3), MTRAP forward primer (5-TGCACA
TGGTCACTTTGAAGA-3), MTRAP reverse primer (5-TCCTTTCCCTTGA
GAGCATCA-3), actin forward primer (5-AGCAGCAGGAATCCACACA-
3), actin reverse primer (5-TGATGGTGCAAGGGTTGTAA-3), Rh1
forward primer (5-ATGTATTTTGCCAGTGGAAT-3), Rh1 reverse primer
(5-TTGTGTGCTTTTATCATCCA-3), Rh2a forward primer (5-CACAGCA
GGAAGTGTAGCTTT-3), Rh2a reverse primer (5-GAACATCATCATTCG
GTTCAA-3), Rh2b forward primer (5-ATGGAAACACATGGTCCAAA-3),
Rh2b reverse primer (5-AACAAACAACTCCTCCAGCA-3), Rh4 forward
primer (5-AGGAAAATCTTCAGGGAAAG-3), Rh4 reverse primer (5-TCT
GAATGTGCATTATCTGC-3), RON5 forward primer (5-GCACTTCGCAA
TATGGGACT-3), RON5 reverse primer (5-ATACCCAAGCAGATCCATC
G-3), Rh5 forward primer (5-ACGAAGAATCAAGAAAATAATCTGACGT
TACT-3), Rh5 reverse primer (5-TGTTGAATGATCTTTAGCATTATTTGT
TTTTATATTCTCTTT-3), AMA1 forward primer (5-GAAAAGGAAATGC
TGAAAAA-3), and AMA1 reverse primer (5-TGGTGTTGTATGTGATGC
TC-3).
The levels of expression of target genes were normalized to the level of
expression of ama1 as described previously (31). The relative concentration of
transcript level for each target gene was then examined as a ratio of the transcript
levels for the EBL-knockout lines to the level for 3D7. Two-sided t tests were
used to test for differences in gene expression levels between 3D7 and EBL-
knockout parasite lines.
RESULTS
Disruption of ebl genes in P. falciparum. To test the role of
the EBL and PfRh protein families, we constructed P. falcip-
arum 3D7 lines in which the genes encoding EBA-175, EBA-
181, and EBA-140 were disrupted singly or in combination
(Fig. 1) (25). This was done using the vectors pCC1 and pCC4,
which contained the genes for human dihydrofolate reductase
(hDHFR) or blasticidin deaminase (bsd), to enable the gener-
ation of parasites that had two genes disrupted by consecutive
transfection of each vector by targeted double-crossover ho-
mologous recombination (Fig. 1A and B) (25). All transfec-
tants were analyzed by Southern blotting to confirm that the
expected targeting event had occurred (Fig. 1C). We generated
the parasite lines 3D7175, 3D7181, and 3D7140, each of
which had a single gene ablated (eba-175, eba-140, and eba-
181, respectively; Fig. 1C). We then used these for a second
round of transfection to generate parasite lines 3D7175/181,
3D7175/140, and 3D7181/140, each of which had two genes
disrupted (Fig. 1C). To confirm that the 3D7 P. falciparum
lines with specific gene knockouts lacked expression of the
expected proteins, we performed immunoblotting with specific
antibodies (Fig. 1D). This showed that 3D7175, 3D7181,
3D7140, 3D7175/181, 3D7175/140, and 3D7181/140 did
not express the expected ligands. Analysis of these lines
showed that 3D7181/140 had deleted the PfRh2b gene, and
consequently, this line was not further studied.
The EBL and PfRh proteins function cooperatively. Having
constructed a set of P. falciparum cloned lines lacking expres-
sion of specific EBL proteins, we performed GIAs to test the
function of specific ligands in merozoite invasion (35). Anti-
bodies to EBA-175 (anti-EBA-175RIII-V), EBA-181 (anti-
EBA-181RIII-V), and EBA-140 (anti-EBA-140F2) (Fig. 2) in-
hibited growth of 3D7 at 16.5% (P  0.05), 10.8% (P  0.05),
and 17.6% (P  0.004), respectively, compared to the level of
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inhibition with control antibodies (Fig. 3), which was consistent
with previous results (11, 14, 44). This was shown to be specific
because the inhibition was not observed in 3D7175,
3D7181, and 3D7140, in which each of these ligands was not
expressed (Fig. 3). Antibodies to PfRh2a/b (anti-Rh2a9) inhib-
ited growth of 3D7 at 35.6%, and in 3D7175 (49%) and
3D7140 (44.3%), in which the EBA-175 and EBA-140 pro-
teins were absent, inhibition was increased to a small but not
FIG. 1. Genetic disruption of the eba-175, eba-181, and eba-140 genes in P. falciparum. (A) The strategy for construction of 3D7 P. falciparum
parasites with single- and double-gene knockouts of the ebl family. The vectors pCC1 and pCC4 were used, allowing selection for hDHFR
(WR99210) and blasticidin deaminase (blasticidin), respectively. Flucytosine (5FC) was used for negative selection to obtain parasites with a
double-crossover recombination event with Saccharomyces cerevisiae cytosine deaminase/uracil phosphoribosyltransferase. The eba-175 and
eba-181 genes were disrupted first using pCC1 and then using eba-140 or eba-181 with pCC4. (B) The eba-140 gene was disrupted in 3D7 using
pCC4 to make a single knockout by double-crossover recombination. (C) Southern blot analysis of 3D7, 3D7175, 3D7181, 3D7140,
3D7175/181, 3D7175/140, and 3D7181/140 to show that pCC1 and pCC4 had integrated into the expected genes by double-crossover
recombination. For the first panel, the restriction enzymes used were EcoRV and MfeI (EBA-175), while for the second panel they were EcoRI
and NcoI (eba-181) and for the third panel they were AgeI, HincII, and BamHI (EBA-140). (D) Immunoblots using specific antibodies to
EBA-175, EBA-181, and EBA-140 to show that the different knockout strains lacked expression of the expected proteins. Shown are
supernatants harvested from 3D7, 3D7175, 3D7181, 3D7140, 3D7175/181, 3D7175/140, and 3D7181/140 that were probed with
anti-EBA175, anti-EBA-181, or anti-EBA-140 antibodies.
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statistically significant extent. This was more evident for
3D7175/140, where growth inhibition in the presence of anti-
Rh2a9 was increased to 60.5% (P  0.004) compared to the
level of inhibition of parental line 3D7. This strongly suggested
that PfRh2a and/or PfRh2b had compensated for the loss of
EBA-175 and EBA-140 function in 3D7, consistent with these
protein families having overlapping roles in merozoite inva-
sion.
Surprisingly, when we tested the anti-Rh2a9 antibodies with
3D7181 and 3D7175/181 parasites, little inhibition was ob-
served, which was in contrast to inhibition by these antibodies
with 3D7, 3D7175, 3D7140, and 3D7175/140 (Fig. 3). Both
3D7181 and 3D7175/181 lack EBA-181 expression (Fig.
1D). To test that PfRh2a and PfRh2b expression was retained
in 3D7181 and 3D7175/181, we performed immunoblotting
with anti-PfRh2a/b antibodies, and the protein was detected in
all parasite lines (data not shown). Both PfRh2a and PfRh2b
proteins were detected in the parental 3D7 line as well as
3D7175, 3D7181, 3D7140, 3D7175/181, and 3D7175/
140. Therefore, abrogation of the inhibitory effect of anti-
PfRh2a/b antibodies on the growth of parasites lacking EBA-
181 was not due to silencing of PfRh2a and PfRh2b expression.
Moreover, 3D7181 and 3D7175/181 represent indepen-
dent eba-181 gene disruption events (Fig. 1), making it un-
likely that mutation of PfRh2a or PfRh2b during ongoing culture
or transfection had affected the function of these ligands or the
ability of Rh2a9 antibodies to inhibit. Our previous data have
suggested that PfRh2a was not functional in the 3D7 parental
parasite (12), suggesting that the inhibition by Rh2a9 antibodies,
which are raised against the common region of PfRh2a/b (Fig. 2),
was principally affecting PfRh2b function. These data suggest that
PfRh2b functions cooperatively with EBA-181 in merozoite inva-
sion. Experiments to show a direct interaction of PfRh2b and
EBA-181 by immunoprecipitation were not successful; this may
be due to the interaction occurring transiently during invasion or
the functional cooperation not requiring direct interaction of the
proteins.
Antibodies against both PfRh and EBL proteins together
increased growth inhibition of P. falciparum. The EBL and
FIG. 2. Structures of the EBA-175, EBA-181, EBA-140, PfRh2a, PfRh2b, and PfRh4 proteins and the positions to which recombinant proteins
were made for use as immunogens to raise antibodies. The red region in EBA-175, EBA-181, and EBA-140 corresponds to region II, which
encompasses the receptor-binding domain. PfRh2a and PfRh2b are identical for most of the N-terminal region and differ only at the C terminus
(green for PfRh2a and blue for PfRh2b). The red cell binding region defined for PfRh4 is shown in yellow, toward the N terminus. The proteins
are drawn to scale, with the sizes shown in amino acids (aa).
FIG. 3. Antibodies to EBL and PfRh2a/b proteins inhibit invasion
of P. falciparum into human erythrocytes. The results of GIAs for 3D7,
3D7175, 3D7175/181, 3D7181, 3D7175/140, 3D7140,
3D7175/140, and 3D7175/181 are shown. The antibodies used are
IgG purified from rabbits, used at 1 mg/ml. Shown are the results of
three independent experiments, with each done in triplicate, using
anti-EBA-175, anti-EBA-181, anti-EBA-140, and anti-PfRh2a/b anti-
bodies which were made to the regions of each protein, as shown in
Fig. 2. The histogram represents 3 independent experiments, per-
formed in triplicate. The error bars show the standard errors of the
means.
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PfRh proteins may have potential as vaccine candidates when
they are used in specific combinations that generate antibodies
to block a broad array of ligands required for merozoite inva-
sion, thereby overcoming functional redundancy among inva-
sion ligands and the capacity for immune evasion (35, 47). To
test this hypothesis, we expressed regions of EBL and PfRh
proteins that we knew generated invasion-inhibitory antibodies
(Fig. 2) and vaccinated rabbits with single proteins as well as
specific combinations.
The combinations that we tested were EBA-175RIII-V/
Rh2a9, EBA-175RIII-V/Rh4.9, and EBA-175RIII-V/Rh2a9/
Rh4.9 (Fig. 2) because of the ability to express large amounts
of soluble protein and previous data suggesting that they were
functionally important members of the protein families in-
volved in merozoite invasion (11, 12, 37, 44, 47). The recom-
binant proteins from each combination were used to immunize
two rabbits, and IgG was purified from serum for use in assays.
We confirmed the specificity and titer of the antibodies by
ELISA with the same fusion protein used to immunize rabbits
(Fig. 4). The ELISAs showed strong reactivity for each com-
bination that included EBA-175RIII-V with Rh2a9 (Fig. 4A),
EBA-175RIII-V with Rh4.9 (Fig. 4B), and EBA-175RIII-V
with both Rh2a9 and Rh4.9 (Fig. 4C). No inhibition was ob-
served for IgG purified from rabbit serum collected before
immunization (prebleed). The titer of antibody was approxi-
mately the same for each antigen, suggesting that the immune
responses were similar and that antigenic competition was not
a major problem. The titer of antibodies was determined for
the second bleed, and they were at levels very similar to those
observed after the third bleed (data not shown). Similar results
were obtained for serum from a second rabbit immunized with
each combination (data not shown). The titers of IgG antibod-
ies from rabbits injected with EBA-175RIII-V, Rh2a9, or
Rh4.9 for the single second bleed were determined, and they
were similar to those induced by the immunogens. This showed
that the antibody response to these antigens was higher than
that when the antigens were used in combinations. Therefore,
any increased inhibitory effect of the antibodies from rabbits
injected with the combination of immunogens is likely to be
due to the combination of antigens used rather than just a
reflection of different antibody titers.
Additionally, we showed that the antibodies reacted to the
native parasite proteins in immunoblots of parasite lines 3D7,
3D7175, FCR3, W2mef175, and W2mefRh4 (Fig. 5). The
anti-EBA-175RIII-V antibodies specifically detected EBA-175
in 3D7, FCR3, and W2mefRh4 but not in 3D7175 (or
W2mef175) (Fig. 5A). Similarly, antibodies obtained from
the rabbits immunized with EBA-175RIII-V/Rh2a9 reacted
with EBA-175 and both PfRh2a and PfRh2b (Fig. 5B). Neither
PfRh2a nor PfRh2b is expressed in FCR3, and the antibodies
detected only EBA-175. The antibodies from the triple-com-
bination immunization (EBA-175RIII-V/Rh2a9/Rh4.9) de-
tected EBA-175, PfRh2a, and PfRh2b; however, it was not
possible to identify PfRh4 in parasite culture supernatant ma-
terial because of the presence of nonspecific bands (44, 47)
(Fig. 5C). Consequently, we performed similar immunoblot-
ting assays using schizont-stage material with the parasite lines
3D7, W2mefRh4, W2mef175, and W2mef (Fig. 5D). This
gave similar results but, importantly, showed that the antibod-
ies detected the expected doublet of approximately 155 kDa
for the PfRh4 protein in 3D7 (faint reactivity) and W2mef175
but not in W2mefRh4 and W2mef, which lack expression of
PfRh4 (44).
As shown above, anti-EBA-175RIII-V antibodies were able
to inhibit 3D7 parasites by 16.5% (Fig. 3); however, when
EBA-175RIII-V and Rh2a9 were coimmunized, growth inhi-
bition was significantly greater (Fig. 6A and B). The IgG an-
tibodies from the first bleed tested inhibited at 46%, and this
increased significantly for the second (57%) and third (72%)
bleeds. In order to dissect the contribution of antibodies to
FIG. 4. Antibody titers for the IgG antibodies purified from rabbits
immunized with the EBA-175, PfRh2a/b, and PfRh4 combinations.
(A) PfRh2a/b and EBA-175 recombinant proteins were coated on
separate plates, and antibodies from rabbits were tested for reactivity.
Prebleed antibodies and PBS were used as negative controls.
(B) PfRh4 and EBA-175 recombinant proteins were coated on sepa-
rate plates, and antibodies from rabbits were tested for reactivity.
Prebleed antibodies and PBS were used as negative controls.
(C) PfRh4, PfRh2a/b, and EBA-175 recombinant proteins were coated
on separate plates, and antibodies from rabbits were tested for reac-
tivity. Prebleed antibodies and PBS were used as negative controls.
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each protein in inhibition of invasion, we tested the ability of
antibodies to inhibit 3D7175. This showed that antibodies to
EBA-175 played a significant role in the inhibitory effect, as
evidenced by the reduced inhibition of 3D7175. However,
IgG from the third bleed inhibited 3D7 and 3D7175 equally,
suggesting that PfRh2a/b antibodies also played an important
role, particularly in the later stages of the immunization sched-
ule. Titration of antibodies from the third bleed showed that
the inhibitory effect was still significant at lower antibody con-
centrations and that 3D7 and 3D7175 were inhibited at
equivalent levels (Fig. 6B). These data show that EBA-
175RIII-V and Rh2a9, as a vaccine combination, were able to
raise antibodies that are more potent in blocking merozoite
invasion than either protein used alone.
Similarly, we tested the ability of a combination of EBA-
175RIII-V and Rh4.9 to raise invasion-inhibitory antibodies
(Fig. 6C). This gave results similar to those for the EBA-
175RIII-V/Rh2a9 combination, and IgG from each of the
bleeds tested was able to inhibit invasion at a significantly
greater level than antibodies raised against each of the ligands
alone. Testing for inhibition of 3D7 and 3D7175 suggested
that antibodies to both EBA-175 and PfRh4 played a signifi-
cant role in the overall inhibitory effect; however, the former
antigen was clearly more important. Titration of IgG antibod-
ies from the third bleed showed that inhibition was significant
at lower concentrations (Fig. 6D).
Finally, we tested antibodies generated by immunization
with the EBA-175RIII-V, Rh2a9, and Rh4.9 proteins for in-
vasion-inhibitory activity (Fig. 6E). The three bleeds tested
from rabbits immunized showed considerably greater levels of
inhibition of both 3D7 and 3D7175 compared to those
achieved by immunization with two antigens (Fig. 6). This was
apparent from the first bleed tested, which showed 78% inhi-
bition of 3D7, and this increased to a maximum of 84% for the
second bleed. Inhibition of 3D7175 again showed that anti-
bodies against both EBA-175 and the PfRh proteins were
important for the overall level of inhibition. Additionally, in
the second and third bleeds, the anti-PfRh response appeared
to have been significantly boosted, as there was a very small
difference in inhibition of 3D7 and 3D7175 (Fig. 6E). This
was also evident in the titration of IgG from the third bleed, for
which there was only a small difference in the inhibition of 3D7
and 3D7175 (Fig. 6F). Importantly, the inhibitory effect could
be titrated, and even at a final concentration of 0.125 mg/ml of
total IgG, the level of inhibition was significant (Fig. 6F).
Overall, these data show that a combination of EBA-
175RIII-V, Rh2a9, and Rh4.9 was able to generate an antibody
response that was more potent than that obtained with immu-
nization using a double-antigen combination. This strongly
supports the idea that an effective immune response that tar-
gets different merozoite invasion pathways can significantly
reduce the growth potential of P. falciparum and validates
these antigens as a potential combination vaccine.
Loss of EBA protein function decreases the fitness of P.
falciparum and selects for increased transcription of some
PfRh genes. To determine if loss of EBL function decreased
the ability of P. falciparum to invade erythrocytes, we used
coculture assays in which we mixed equal numbers of the
mutant parasites with the parental line 3D7 and monitored
their ability to grow and expand using quantitative PCR
(qPCR) over a 5-week period that encompassed approximately
17 generations (Fig. 7). Comparison of the growth rate of the
single-knockout strains 3D7175, 3D7181, and 3D7140
showed that loss of function of the corresponding ligand had a
small fitness cost, reflected by a reduced growth rate compared
to that for parental line 3D7, suggesting that they were not able
to invade as efficiently. Interestingly, similar levels of growth
rate reduction were obtained for 3D7175/140 and 3D7175/
181 when the growth rates were compared directly with the
3D7 growth rate. Therefore, loss of EBL function in 3D7
parasites decreases the fitness of the parasite most likely by
decreasing the efficiency of merozoite invasion.
We determined if there were transcriptional differences be-
tween 3D7 and the different parasite strains lacking expression
of specific ebl genes (Fig. 8). Initially, Affymetrix arrays were
used, and the only significant transcriptional changes detected,
for genes likely to be involved in merozoite invasion, were in
the PfRh gene family (data not shown). To analyze this in more
detail, we used qPCR on cDNA made from 3D7, 3D7175,
3D7181, 3D7140, 3D7175/181, and 3D7175/140 (Fig. 8).
FIG. 5. Antibodies react with the corresponding EBL and PfRh
proteins in immunoblots of supernatants or schizont preparations
made from 3D7, 3D7175, FCR3, W2mefRh4, W2mef, and
W2mef175. (A) Supernatants from 3D7, 3D7175, FCR3, and
W2mefRh4 were separated by SDS-PAGE, and filters were probed
with antibodies from rabbits immunized with EBA-175. 3D7175 lacks
expression of EBA-175. (B) Supernatants from 3D7, 3D7175, FCR3,
and W2mefRh4 were separated by SDS-PAGE, and filters were
probed with antibodies from rabbits immunized with EBA-175 and
PfRh2a/b. (C) Supernatants from 3D7, 3D7175, FCR3, and
W2mefRh4 were separated by SDS-PAGE, and filters were probed
with antibodies from rabbits immunized with EBA-175, PfRh2a/b, and
PfRh4. FCR3 lacks expression of PfRh2a and PfRh2b, while 3D7175
does not express EBA-175. W2mefRh4 does not express PfRh4.
(D) Schizonts from W2mef, W2mef175, W2mefRh4, and 3D7 were
separated by SDS-PAGE, and filters were probed with antibodies from
rabbits immunized with EBA-175, PfRh2a/b, and PfRh4. W2mef175
does not express EBA-175 but does express PfRh4. W2mefRh4 does
not express PfRh4 but does express EBA-175. W2mef does not express
PfRh4.
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As controls, we also determined the level of transcription for
actin and two genes involved in merozoite invasion, i.e., mtrap
and ron5 (5, 38). The most significant change in transcription
of the PfRh family occurred in the 3D7 lines in which the
eba-175 gene had been disrupted either singly or in combina-
tion with other ebl genes, where mRNA levels from PfRh4 were
increased 2- to 3-fold (Fig. 8A, D, and E). The significant
increase in transcription of PfRh4 in some parasite lines lack-
ing expression of eba-175 suggests that a specific loss function
selects for increased transcription of the PfRh4 family to func-
tionally compensate for its role in merozoite invasion.
DISCUSSION
Invasion of P. falciparum merozoites into human erythro-
cytes involves multiple ligand-receptor interactions. The EBL
and PfRh families are central to host cell recognition and are
responsible for mediating distinct invasion pathways (for re-
views, see references 8 and 15). We have used single- and
double-gene knockouts to analyze the role of these proteins in
invasion and explore their potential for use as vaccine candi-
dates in a combination that would block a broad array of
invasion pathways (4, 25, 47). Our findings suggest that the role
of these two protein families is overlapping, as deletion of EBL
members can be functionally compensated for by other PfRh
proteins in merozoite invasion. Additionally, our data suggest
that PfRh2b interacts functionally with EBA-181, providing
evidence that these proteins act cooperatively in merozoite
invasion.
The possibility that EBA-175 and PfRh4 have a complemen-
tary function has been suggested previously (44). Disruption of
FIG. 6. Antibodies from rabbits immunized with EBA-175, PfRh2a/b, and PfRh4 inhibit growth of P. falciparum. (A) Results of GIAs of 3D7
and 3D7175 using IgG antibodies from rabbits immunized with a combination of EBA-175 and PfRh2a/b. (B) Titration of antibodies from rabbits
immunized with a combination of EBA-175 and PfRh2a/b tested in GIAs with 3D7 and 3D7175 parasites. (C) Results of GIAs of 3D7 and
3D7175 using IgG antibodies from rabbits immunized with a combination of EBA-175 and PfRh4. (D) Titration of antibodies from rabbits
immunized with a combination of EBA-175 and PfRh4 tested in GIAs with 3D7 and 3D7175 parasites. (E) Results of GIAs of 3D7 and 3D7175
using IgG antibodies from rabbits immunized with a combination of EBA-175/PfRh4 and PfRh2a/b. (F) Titration of antibodies from rabbits
immunized with a combination of EBA-175, PfRh4, and PfRh2a/b tested in GIAs with 3D7 and 3D7175 parasites.
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the eba-175 gene or selection of W2mef or Dd2 parasites by
growth in neuraminidase-treated erythrocytes (which removes
the sialic acid-dependent receptor) resulted in parasites in
which PfRh4 transcription was activated (14, 44). This sug-
gested that PfRh4 expression compensated for the loss of
EBA-175 function in merozoite invasion. The ability of anti-
PfRh2a/b antibodies to more efficiently inhibit invasion in par-
asites lacking EBA-175 and/or EBA-140 function is consistent
with a similar compensatory mechanism existing between these
two ligands in 3D7 parasites. Interaction of EBA-175 with its
receptor, glycophorin A, on the erythrocyte restores basal cy-
tosolic calcium levels in the merozoite, resulting in release of
the rhoptry contents, and it is possible that PfRh proteins
perform the same function (42). Thus, it is likely that EBL and
PfRh proteins bind the erythrocyte via specific receptors, con-
firming identification of the appropriate cell for invasion and
then activation of signals for subsequent events, such as
rhoptry release, for entry of the parasite. The differential ex-
pression and function of these two protein families provides a
mechanism of phenotypic variation in the P. falciparum popu-
lation for evasion of host responses and to overcome the poly-
morphic nature of the erythrocyte surface in the human pop-
ulation (12).
PfRh2b antibodies do not inhibit merozoite invasion when
EBA-181 is not expressed, suggesting that these two proteins in
some way cooperate and that loss of one ablates function in the
other. Interestingly, when we disrupted the eba-181 and eba-
140 genes, the resulting parasites had deleted the PfRh2b gene.
This may have occurred as PfRh2b was no longer functional
with the loss of EBA-181 expression and was therefore easily
lost from the genome by recombination between the closely
linked and highly homologous gene PfRh2a (12). We were
unable to coimmunoprecipitate PfRh2b and EBA-181 from
3D7 to demonstrate a direct interaction. It is possible that
PfRh2b and EBA-181 interact transiently during merozoite
invasion and immunoprecipitation experiments before or after
this rapid event using schizonts or culture supernatants, mak-
ing capture of these interacting proteins very difficult. The
interaction of apical membrane antigen 1 (AMA-1) and the
RON complex in both T. gondii and P. falciparum occurs only
during tachyzoite or merozoite invasion, and they are located
in different subcellular locations before egress of the invasive
forms (2, 20, 38). Interestingly, the EBL proteins are located in
micronemes, while PfRh proteins appear to be in the neck of
the rhoptries so that they could associate when the micronemal
proteins are released (12, 33, 40). It is likely that other EBL
and PfRh proteins besides PfRh2b and EBA-181 also interact
FIG. 7. P. falciparum lines lacking expression of specific EBL pro-
teins are less fit than the parental line 3D7, as shown in growth
competition assays. The parasite lines 3D7175, 3D7181, 3D7140,
3D7175/181, and 3D7175/140 were mixed in approximately equal
amounts with the 3D7 parental line, and the growth of each was
monitored by qPCR over a 5-week period. The log10 ratio of the
parent/knockout (KO) strain was calculated. The P values shown rep-
resent the probability of a difference in growth rate compared to the
3D7 growth rate and were calculated using a Student t test.
FIG. 8. 3D7 ebl gene-knockout lines vary in the relative expression
of PfRh4 in late-stage schizonts. The genes whose transcriptional levels
were compared included actin, eba-140, eba-175, eba-181, mtrap,
PfRh1, PfRh2a, PfRh2b, PfRh4, ron5, and PfRh5. The histograms show
the relative concentration (knockout strain/3D7) as a ratio for the 11
genes used. Values are given as means  standard errors of the means.
The statistical analysis used was the Student t test. The bars show the
results of three independent experiments done in triplicate. (A) Com-
parison of transcriptional levels between 3D7 and 3D7175 (which
lacks expression of EBA-175); (B) comparison of transcriptional levels
between 3D7 and 3D7181 (which lacks expression of EBA-181);
(C) comparison of transcriptional levels between 3D7 and 3D7140
(which lacks expression of EBA-140); (D) comparison of transcrip-
tional levels between 3D7 and 3D7175/181 (which lacks expression of
EBA-175 and EBA-181); (E) comparison of transcriptional levels be-
tween 3D7 and 3D7175/140 (which lacks expression of EBA-175 and
EBA-140).
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functionally during merozoite invasion, and it may be possible
to demonstrate these interactions using purified viable mero-
zoites in the process of erythrocyte invasion (7).
The cooperative function of EBL and PfRh proteins in mer-
ozoite invasion has important implications with respect to their
potential as vaccine candidates. We chose to test EBA-175 in
combination with other PfRh proteins because previous stud-
ies have suggested that it plays a more important role than
EBA-181 and EBA-140 in at least some P. falciparum lines
(22). Additionally, the eba-175 gene is more polymorphic in P.
falciparum populations than other members of the EBL family,
consistent with it being under strong diversifying selective pres-
sure and therefore an important target of immunity (6). Fur-
thermore, recent studies suggest that EBA-175 is a target of
acquired invasion-inhibitory antibodies in humans (35). We
have shown that the small number of polymorphisms identified
in EBA-181 and EBA-140 can decrease the ability of these
ligands to bind their receptor and reduce their function such
that, in some strains, they do not contribute measurably to
invasion (22, 24). The lack of diversifying selection for EBA-
140 and EBA-181 and accumulation of polymorphisms that
decrease their function are consistent with them playing a
lesser role than EBA-175 in merozoite invasion in the P. fal-
ciparum population. Our demonstration that PfRh2b and
EBA-181 function cooperatively suggests that only one of
these needs to be included in a vaccine combination to block
the invasion pathways mediated by these proteins. Antibodies
to the PfRh4 receptor binding site can inhibit merozoite inva-
sion, suggesting that this may be an important component of an
EBL/PfRh combination vaccine. It would be challenging and
expensive to include all EBL and PfRh proteins in a vaccine
combination, and we therefore chose to test EBA-175 in com-
bination with PfRh2a/b and/or PfRh4, as it appears to be
functionally the most important member of the EBL family.
While we have tested EBA-175, PfRh2a/b, and PfRh4 as
combinations for their ability to raise invasion-inhibitory anti-
bodies, it has not yet been possible to include PfRh5 (3, 17). It
is likely that PfRh5 is potentially important as a candidate
vaccine molecule in combination with other members of the
PfRh and EBL families. It has not been possible to disrupt the
gene for PfRh5 in any parasite line that we have so far tested,
suggesting that as a member of this family of proteins it plays
a key function in invasion (3, 17). However, it is difficult to
express this protein in a recombinant form that enables pro-
duction of efficient invasion-inhibitory antibodies, and at this
stage its importance as a vaccine candidate in combination with
other EBL and PfRh proteins remains to be determined.
Comparison of growth rates for the different EBL-knockout
strains showed that loss of function of this family of proteins
results in a measurable decrease in fitness compared to that of
the parental strain. However, we also observed increased tran-
scription of the PfRh4 gene, suggesting that this has to some
degree complemented the eba-175 function in merozoite inva-
sion. Consistent with previous data, in the P. falciparum lines in
which we ablated EBA-175 function, PfRh4 transcription was
significantly increased. These results are similar to previous
results of studies in which either EBA-175 function has been
blocked by gene disruption or, alternatively, the corresponding
receptor has been removed by neuraminidase treatment of the
red blood cell receptor (14, 44). This resulted in selection of
parasites in which the PfRh4 gene was activated to express the
corresponding parasite ligand that mediated an invasion path-
way that we have subsequently identified through the host
receptor CR1 (46). Thus, it is apparent that P. falciparum
strains that can utilize a larger number of EBL and PfRh
proteins may be more efficient at invading the host erythrocyte
and therefore have a survival advantage. This may be because
a larger array of ligands provides an increased affinity of bind-
ing to the host erythrocyte and therefore increases the likeli-
hood of successful invasion through delivery of the appropriate
signal (42), a property that may also be related to virulence
potential (4, 12).
The combination of EBA-175, PfRh2a/b, and PfRh4 pro-
teins generated antibodies that were potent inhibitors of mer-
ozoite invasion, and this raises interest in their potential as
combination vaccine candidates. Antibodies to the region of
EBA-175 tested appeared to be most important in the overall
inhibitory effect; however, antibodies to the PfRh2a/b and
PfRh4 domains used were also highly inhibitory in combina-
tion with EBA-175 antibodies, particularly for rabbit bleeds
taken later in the immunization schedule, suggesting that the
latter antigens may be less immunogenic than EBA-175. Nev-
ertheless, these results have shown that a combination of EBL
and PfRh proteins can be used as a combination vaccine to
raise antibodies that are capable of efficiently blocking mero-
zoite invasion.
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